Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,892 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023.
Igarashi A, Tanaka S, De Moor R, Li N, Hirozane M, Wu DB, Hong LW, Yu DY, Hashim M, Hutton B, Tantakoun K, Olsen C, Fashami FM, Samjoo IA, Cameron C. Igarashi A, et al. Among authors: yu dy. Adv Ther. 2025 Jan 6. doi: 10.1007/s12325-024-03087-2. Online ahead of print. Adv Ther. 2025. PMID: 39760977 No abstract available.
Effect of radiotherapy exposure on fruquintinib plus sintilimab treatment in refractory microsatellite stable metastatic colorectal cancer: a prospective observation study.
Cheng M, Jin M, Yang S, Zhao L, Yu D, Lin Z, Li P, Huang C, Liu J, Wang J, Xue J, Ma H, Hu J, Yang K, Zhang T, Liu H. Cheng M, et al. Among authors: yu d. J Immunother Cancer. 2025 Jan 4;13(1):e009415. doi: 10.1136/jitc-2024-009415. J Immunother Cancer. 2025. PMID: 39755582 Free article.
13,892 results
You have reached the last available page of results. Please see the User Guide for more information.